rs114542403

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 2P and 16B. PM1BP4_StrongBP6_Very_StrongBS2

The NM_020699.4(GATAD2B):​c.1229C>G​(p.Ala410Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000292 in 1,613,526 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0016 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00015 ( 1 hom. )

Consequence

GATAD2B
NM_020699.4 missense

Scores

3
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.28

Publications

1 publications found
Variant links:
Genes affected
GATAD2B (HGNC:30778): (GATA zinc finger domain containing 2B) This gene encodes a zinc finger protein transcriptional repressor. The encoded protein is part of the methyl-CpG-binding protein-1 complex, which represses gene expression by deacetylating methylated nucleosomes. Mutations in this gene are linked to intellectual disability and dysmorphic features associated with cognitive disability. [provided by RefSeq, Jun 2016]
GATAD2B Gene-Disease associations (from GenCC):
  • severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, Illumina, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 6 uncertain in NM_020699.4
BP4
Computational evidence support a benign effect (MetaRNN=0.006309688).
BP6
Variant 1-153813440-G-C is Benign according to our data. Variant chr1-153813440-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 211065.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 247 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GATAD2BNM_020699.4 linkc.1229C>G p.Ala410Gly missense_variant Exon 8 of 11 ENST00000368655.5 NP_065750.1
GATAD2BXM_047426115.1 linkc.1232C>G p.Ala411Gly missense_variant Exon 8 of 11 XP_047282071.1
GATAD2BXM_047426117.1 linkc.1229C>G p.Ala410Gly missense_variant Exon 8 of 11 XP_047282073.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GATAD2BENST00000368655.5 linkc.1229C>G p.Ala410Gly missense_variant Exon 8 of 11 1 NM_020699.4 ENSP00000357644.4

Frequencies

GnomAD3 genomes
AF:
0.00162
AC:
247
AN:
152110
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00582
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000328
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000370
AC:
93
AN:
251108
AF XY:
0.000273
show subpopulations
Gnomad AFR exome
AF:
0.00523
Gnomad AMR exome
AF:
0.000203
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000153
AC:
224
AN:
1461298
Hom.:
1
Cov.:
31
AF XY:
0.000127
AC XY:
92
AN XY:
726992
show subpopulations
African (AFR)
AF:
0.00571
AC:
191
AN:
33464
American (AMR)
AF:
0.000291
AC:
13
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86248
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53414
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5758
European-Non Finnish (NFE)
AF:
0.00000180
AC:
2
AN:
1111482
Other (OTH)
AF:
0.000282
AC:
17
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
13
25
38
50
63
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00162
AC:
247
AN:
152228
Hom.:
1
Cov.:
32
AF XY:
0.00152
AC XY:
113
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.00580
AC:
241
AN:
41534
American (AMR)
AF:
0.000327
AC:
5
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10598
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68016
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
13
26
38
51
64
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000272
Hom.:
0
Bravo
AF:
0.00185
ESP6500AA
AF:
0.00477
AC:
21
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000379
AC:
46

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 22, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 24, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
Dec 23, 2016
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.065
T;T;.
Eigen
Benign
-0.16
Eigen_PC
Benign
0.062
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.0
.;.;T
M_CAP
Benign
0.0027
T
MetaRNN
Benign
0.0063
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.075
N;N;.
PhyloP100
1.3
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
-1.7
N;.;.
REVEL
Benign
0.12
Sift
Benign
0.16
T;.;.
Sift4G
Benign
0.41
T;T;T
Vest4
0.18
ClinPred
0.034
T
GERP RS
5.2
Varity_R
0.17
gMVP
0.26
Mutation Taster
=72/28
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs114542403; hg19: chr1-153785916; API